Pfizer’s First Gene Treatment For A Rare Genetic Bleeding Condition Gets Approved By The FDA
The uncommon genetic bleeding condition treatment developed by Pfizer was cleared by the Food and Drug Administration on Friday, marking the company’s first clearance for gene therapy in the United States. The medication, which will be sold under the brand name Beqvez, was approved by the agency for use in people with moderate to severe…









